Results 151 to 160 of about 19,945,001 (395)
Prognostic value of cystatin C in patients with nasopharyngeal carcinoma: a retrospective study of 1063 patients [PDF]
OBJECTIVE: Patients with nasopharyngeal carcinoma experience highly variable outcomes despite receiving similar therapeutic regimens. Identifying biomarkers that predict survival and guide individualized therapy is urgently needed.
Chen, Li-Zhen+6 more
core +3 more sources
The METAB‐HTX trial is a prospective cohort study, evaluating cardiac and systemic metabolism among heart transplant recipients. Myocardial function, energetic and metabolism, allograft vasculopathy, allograft rejection, glucometabolism, lipometabolism, liver‐ and kidney function, leucocyte signatures and thromboinflammation will be evaluated ...
Amin Polzin+21 more
wiley +1 more source
Cystatin C and lactoferrin concentrations in biological fluids as possible prognostic factors in eye tumor development [PDF]
Objectives. To investigate the possible role of cystatin C in eye biological fluids locally and in serum and lactoferrin revealing anti-tumor activity in eye tumor development. Background.
Ananthi S+19 more
core +1 more source
Insulin‐like growth factor‐binding protein‐7 (IGFBP7) and heart failure (HF) risk: the PREVEND study. CI, confidence interval; HR, hazard ratio. Abstract Aim Senescence is a major risk factor for heart failure (HF), and insulin‐like growth factor‐binding protein‐7 (IGFBP7) has been identified as an important senescence‐inducing factor.
Sabrina Abou Kamar+9 more
wiley +1 more source
A note on duality theorems in mass transportation [PDF]
The duality theory of the Monge-Kantorovich transport problem is investigated in an abstract measure theoretic framework. Let $(\mathcal{X},\mathcal{F},\mu)$ and $(\mathcal{Y},\mathcal{G},\nu)$ be any probability spaces and $c:\mathcal{X}\times\mathcal{Y}\rightarrow\mathbb{R}$ a measurable cost function such that $f_1+g_1\le c\le f_2+g_2$ for some $f_1,
arxiv
Markers of progression to heart failure (HF). Gal‐4, galectin‐4; GDF‐15, growth differentiation factor 15; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; ST2, suppression of tumorigenicity‐2. ABSTRACT Aims Biomarkers associated with asymptomatic ventricular dysfunction might improve risk stratification and identify pathways leading to heart ...
Anna Dieden+23 more
wiley +1 more source
Current and novel biomarkers in cardiogenic shock
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko+5 more
wiley +1 more source
Background All of the components of Metabolic syndrome (MetS) have been regarded as risk factors for coronary artery disease (CAD). Early detection of CAD in asymptomatic patients with MetS remains a challenge.
Qing Xie+5 more
doaj +1 more source
Clinical utility of serum cystatin C in predicting coronary artery disease [PDF]
Background: There is limited data regarding the clinical utility of cystatin C in patients with stable coronary artery disease (CAD). The aim of this study was to determine the predictive value of cystatin C for the presence and severity of CAD and the ...
Abali, Gülcan+3 more
core +1 more source
Evaluation of Serum Cystatin C as an Indicator of Glomerular Filtration Rate and its Correlations to other Biomarkers in Detection of Pre-eclampsia. [PDF]
Background: The Glomerular Filtration Rate (GFR) is the best indicator of renal function. Serum cystatin C has been introduced as an endogenous marker of GFR. However, there are conflicting reports regarding its use in pregnancy and pre-eclampsia.
Beheiry, Hind M.+5 more
core +2 more sources